[
1. Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016;139(Suppl 1):318-32410.1111/jnc.1369127401947
]Search in Google Scholar
[
2. Brundin P, Nath A, Beckham JD. Is COVID-19 a perfect storm for Parkinson’s disease?. Trends Neurosci. 2020; 43(12):931-93310.1016/j.tins.2020.10.009757768233158605
]Search in Google Scholar
[
3. Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20(5):385-39710.1016/S1474-4422(21)00030-2818563333894193
]Search in Google Scholar
[
4. Cerri S, Mus L, Blandini F. Parkinson’s Disease in Women and Men: What’s the Difference? J Parkinsons Dis. 2019; 9(3):501-51510.3233/JPD-191683
]Search in Google Scholar
[
5. Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 2020; 36(1):1-1210.1016/j.cger.2019.08.002690538131733690
]Search in Google Scholar
[
6. Goerttler T, Kwon EH, Fleischer M, Stettner M, Tönges L, Klebe S. SARS-CoV-2, COVID-19 and Parkinson’s Disease-Many Issues Need to Be Clarified-A Critical Review. Brain Sci. 2022; 12(4):45610.3390/brainsci12040456902845035447986
]Search in Google Scholar
[
7. Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, Paul JJ, Gaber H, Skrahina V, Bornstein NM, Yahalom G. A case of probable Parkinson’s disease after SARS-CoV-2 infection. Lancet Neurol. 2020; 19(10):804-80510.1016/S1474-4422(20)30305-7749429532949534
]Search in Google Scholar
[
8. Faber I, Brandão PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F. Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case. Mov Disord. 2020; 35(10):1721-172210.1002/mds.28277746109332815213
]Search in Google Scholar
[
9. Méndez-Guerrero A, Laespada-García MI, Gómez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, Rábano-Suárez P, Álvarez-Torres E, de Fuenmayor-Fernández de la Hoz CP, Vega Pérez D, Rodríguez-Montalbán R, Pérez-Rivilla A, Sayas Catalán J, Ramos-González A, González de la Aleja J. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020; 95(15):e2109-e211810.1212/WNL.000000000001028232641525
]Search in Google Scholar
[
10. Rao AR, Hidayathullah SM, Hegde K, Adhikari P. Parkinsonism: An emerging post COVID sequelae. IDCases. 2022; 27:e0138810.1016/j.idcr.2022.e01388873323535018281
]Search in Google Scholar
[
11. Boika AV. A Post-COVID-19 Parkinsonism in the Future? Mov Disord. 2020; 35(7):109410.1002/mds.28117
]Search in Google Scholar
[
12. Drelich-Zbroja A, Cheda M, Kuczyńska M, Dąbrowska I, Kopyto E, Halczuk I. Parkinson’s Disease in Light of the COVID-19 Pandemic. Brain Sci. 2022; 12(2):14310.3390/brainsci12020143886994235203906
]Search in Google Scholar
[
13. Lingor P, Demleitner AF, Wolff AW, Feneberg E. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t. J Neural Transm. 2022; 129(9):1155-116710.1007/s00702-022-02500-w901349235434769
]Search in Google Scholar
[
14. Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain. 2017; 140(8):2246-225110.1093/brain/awx17728899018
]Search in Google Scholar
[
15. Baizabal-Carvallo JF, Alonso-Juarez M. The role of viruses in the pathogenesis of Parkinson’s disease. Neural Regen Res. 2021; 16(6):1200-120110.4103/1673-5374.300437822413833269775
]Search in Google Scholar
[
16. Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res. 2021; 14:6349-638110.2147/JIR.S333887864320134876830
]Search in Google Scholar
[
17. Semerdzhiev SA, Fakhree MAA, Segers-Nolten I, Blum C, Claessens MMAE. Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation. ACS Chem Neurosci. 2022; 13(1):143-15010.1021/acschemneuro.1c00666873982834860005
]Search in Google Scholar
[
18. Wright JW, Harding JW. Importance of the brain Angiotensin system in Parkinson’s disease. Parkinsons Dis. 2012; 2012:86092310.1155/2012/860923
]Search in Google Scholar
[
19. Leta V, Boura I, van Wamelen DJ, Rodriguez-Violante M, Antonini A, Chaudhuri KR. Covid-19 and Parkinson’s disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism. Int Rev Neurobiol. 2022; 165:63-8910.1016/bs.irn.2022.04.004935751436208907
]Search in Google Scholar
